Literature DB >> 25888306

New drug for hepatitis C contributes to 13% rise in spending on prescription drugs in US.

Michael McCarthy1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25888306     DOI： 10.1136/bmj.h2055

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.

Authors:  Sarah Kattakuzhy; Eleanor Wilson; Sreetha Sidharthan; Zayani Sims; Mary McLaughlin; Angie Price; Rachel Silk; Chloe Gross; Elizabeth Akoth; Maryellen McManus; Benjamin Emmanuel; Shikha Shrivastava; Lydia Tang; Amy Nelson; Gebeyehu Teferi; Jose Chavez; Brian Lam; Hongmei Mo; Anuoluwapo Osinusi; Michael A Polis; Henry Masur; Anita Kohli; Shyamasundaran Kottilil
Journal:  Clin Infect Dis       Date:  2015-10-26       Impact factor: 9.079

2.  Estimating the Effect of Health Insurance on Personal Prescription Drug Importation.

Authors:  Andrew R Zullo; Chanelle J Howe; Omar Galárraga
Journal:  Med Care Res Rev       Date:  2016-08-03       Impact factor: 3.929

3.  Drug Pricing Evolution in Hepatitis C.

Authors:  Nathalie Vernaz; François Girardin; Nicolas Goossens; Urs Brügger; Marco Riguzzi; Arnaud Perrier; Francesco Negro
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

4.  Suppression of Drug Resistance in Dengue Virus.

Authors:  Roberto Mateo; Claude M Nagamine; Karla Kirkegaard
Journal:  MBio       Date:  2015-12-15       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.